Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 3, 2009, Pages 301-303

  Kasper, Susan ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Androgen receptor; Cancer stem cell; Prostate; Review

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANDROGEN RECEPTOR; CD133 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; STEM CELL ANTIGEN 1;

CANCER STEM CELL; CELL CULTURE; CELL HETEROGENEITY; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL RENEWAL; CLONAL VARIATION; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RECURRENT CANCER; REVIEW; TUMOR CELL;

ANIMALS; EPITHELIAL CELLS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 65349157651     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.12.012     Document Type: Review

References (39)

1. Polyak K., and Hahn W.C. Roots and stems: Stem cells in cancer. Nat Med 12 (2006) 296-300
2. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51 (2004) 1-28
3. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3 (1997) 730-737
4. Krivtsov A.V., and Armstrong S.A. MLL translocations, histone modifications and leukemia stem-cell development. Nat Rev Cancer 7 (2007) 823-833
5. Bell D.R., and Van Zant G. Stem cells, aging, and cancer: Inevitabilities and outcomes. Oncogene 23 (2004) 7290-7296
6. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7 (2006) 21-33
7. Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 4 (2008) 193-201
8. Maitland N.J., and Collins A.T. Prostate cancer stem cells: A new target for therapy. J Clin Oncol 26 (2008) 2862-2870
9. Taylor R.A., and Risbridger G.P. The path toward identifying prostatic stem cells. Differentiation 76 (2008) 671-681
10. LaMarca H.L., and Rosen J.M. Minireview: Hormones and mammary cell fate-what will I become when I grow up?. Endocrinology 149 (2008) 4317-4321
11. Humphries A., and Wright N.A. Colonic crypt organization and tumorigenesis. Nat Rev Cancer 8 (2008) 415-424
12. Das S., Srikanth M., and Kessler J.A. Cancer stem cells and glioma. Nat Clin Pract Neurol 4 (2008) 427-435
13. Nieto Y., Jones R.B., and Shpall E.J. Stem-cell transplantation for the treatment of advanced solid tumors. Springer Semin Immunopathol 26 (2004) 31-56
14. Clarke M.F., Dick J.E., Dirks P.B., et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66 (2006) 9339-9344
15. Isaacs J.T. Control of cell proliferation and death in the normal and neoplastic prostate: A stem cell model. In: Rogers C.H., Coffey D.S., Cunha G.R., et al. (Eds). Benign prostatic hyperplasia (1985), National Institutes of Health, Bethesda 85-94
16. Kyprianou N., and Isaacs J.T. Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. Endocrinology 123 (1988) 2124-2131
17. De Marzo A.M., Nelson W.G., Meeker A.K., et al. Stem cell features of benign and malignant prostate epithelial cells. J Urol 160 (1998) 2381-2392
18. Rizzo S., Attard G., and Hudson D.L. Prostate epithelial stem cells. Cell Prolif 38 (2005) 363-374
19. Gu G., Yuan J., Wills M.L., et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67 (2007) 4807-4815
20. Isaacs J.T. The biology of hormone refractory prostate cancer. Why does it develop?. Urol Clin North Am 26 (1999) 263-273
21. Collins A.T., and Maitland N.J. Prostate cancer stem cells. Eur J Cancer 42 (2006) 1213-1218
22. Robinson E.J., Neal D.E., and Collins A.T. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37 (1998) 149-160
23. Collins A.T., Berry P.A., Hyde C., et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65 (2005) 10946-10951
24. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
25. Tang D.G., Patrawala L., Calhoun T., et al. Prostate cancer stem/progenitor cells: Identification, characterization, and implications. Mol Carcinog 46 (2007) 1-14
26. Burger P.E., Xiong X., Coetzee S., et al. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 102 (2005) 7180-7185
27. Richardson G.D., Robson C.N., Lang S.H., et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117 (2004) 3539-3545
28. Huss W.J., Gray D.R., Greenberg N.M., et al. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res 65 (2005) 6640-6650
29. Lawson D.A., Xin L., Lukacs R.U., et al. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 104 (2007) 181-186
30. Patrawala L., Calhoun T., Schneider-Broussard R., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 (2006) 1696-1708
31. Hurt E.M., Kawasaki B.T., Klarmann G.J., et al. CD44(+)CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98 (2008) 756-765
32. Holmes C., and Stanford W.L. Concise review: Stem cell antigen-1: Expression, function, and enigma. Stem Cells 25 (2007) 1339-1347
33. Xin L., Lawson D.A., and Witte O.N. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102 (2005) 6942-6947
34. Fargeas C.A., Joester A., Missol-Kolka E., et al. Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci 117 (2004) 4301-4311
35. Leong K.G., Wang B.-E., and Johnson L. Generation of a prostate from a single adult stem cell. Nature 456 (2008) 804-808
36. Mizrak D., Brittan M., and Alison M.R. CD133: molecule of the moment. J Pathol 214 (2008) 3-9
37. - cancer cells are similarly tumorigenic. Cancer Res 65 (2005) 6207-6219
38. Goodell M.A., Rosenzweig M., Kim H., et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3 (1997) 1337-1345
39. Brown M.D., Gilmore P.E., Hart C.A., et al. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67 (2007) 1384-1396